Ultragenyx Pharmaceutical Current Deferred Revenue (Quarterly) Insights

Ultragenyx Pharmaceutical, Inc. (RARE)

22.78 +3.06 (+15.52%) USD | NASDAQ | Dec 30, 16:00

22.45 -0.33 (-1.45%) After-Hours: 16:32

View Current Deferred Revenue (Quarterly) for RARE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
Amicus Therapeutics, Inc.	--
Geron Corp.	--
Vertex Pharmaceuticals, Inc.	--
Fortress Biotech, Inc.	--